Insider · CIK 0001861926

SAHA SAURABH

Reports to the SEC for 2 companies · LONDON

sec.gov

Transactions

Companies

Filings

CIK

0001861926

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-05-14	CLVTCLARIVATE PLCA Award	Director	AAward	+62.3K sh	—	—	170,601
2026-05-13	CLVTCLARIVATE PLCF Tax Payment	Director	FTax Payment	−8,178 sh	$2.44	−$20K	108,337
2025-07-21	Centessa Pharmaceuticals plcM Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	+55K sh	$3.85	+$212K	276,017
2025-07-21	Centessa Pharmaceuticals plcS Sale	Director, Chief Executive Officer	SSale	−55K sh	$15.92	−$876K	221,017
2025-07-21	Centessa Pharmaceuticals plcShare Option (right to buy)M Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	−55K sh	—	—	150,000
2025-06-20	Centessa Pharmaceuticals plcM Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	+55K sh	$3.85	+$212K	276,017
2025-06-20	Centessa Pharmaceuticals plcS Sale	Director, Chief Executive Officer	SSale	−55K sh	$12.63	−$695K	221,017
2025-06-20	Centessa Pharmaceuticals plcShare Option (right to buy)M Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	−55K sh	—	—	205,000
2025-05-20	Centessa Pharmaceuticals plcM Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	+55K sh	$3.85	+$212K	276,017
2025-05-20	Centessa Pharmaceuticals plcS Sale	Director, Chief Executive Officer	SSale	−55K sh	$12.71	−$699K	221,017
2025-05-20	Centessa Pharmaceuticals plcShare Option (right to buy)M Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	−55K sh	—	—	260,000
2025-05-07	CLVTCLARIVATE PLCA Award	Director	AAward	+39.5K sh	—	—	116,515
2025-05-06	CLVTCLARIVATE PLCF Tax Payment	Director	FTax Payment	−4,974 sh	$4.17	−$20.7K	77,042
2025-04-22	Centessa Pharmaceuticals plcS Sale	Director, Chief Executive Officer	SSale	−40.3K sh	$12.43	−$501K	221,017
2025-04-21	Centessa Pharmaceuticals plcS Sale	Director, Chief Executive Officer	SSale	−14.7K sh	$12.29	−$180K	261,361
2025-03-20	Centessa Pharmaceuticals plcS Sale	Director, Chief Executive Officer	SSale	−55K sh	$16.69	−$918K	276,017
2025-03-03	CLVTCLARIVATE PLCP Purchase	Director	PPurchase	+58.3K sh	$4.36	+$254K	82,016
2025-02-20	Centessa Pharmaceuticals plcS Sale	Director, Chief Executive Officer	SSale	−54.2K sh	$15.92	−$863K	331,792
2025-02-20	Centessa Pharmaceuticals plcS Sale	Director, Chief Executive Officer	SSale	−775 sh	$16.54	−$12.8K	331,017
2025-02-03	Centessa Pharmaceuticals plcShare Option (right to buy)A Award	Director, Chief Executive Officer	AAward	+900K sh	—	—	900,000
2025-02-01	Centessa Pharmaceuticals plcF Tax Payment	Director, Chief Executive Officer	FTax Payment	−43.4K sh	$16.92	−$734K	386,017
2025-01-21	Centessa Pharmaceuticals plcS Sale	Director, Chief Executive Officer	SSale	−53.4K sh	$15.76	−$841K	431,023
2025-01-21	Centessa Pharmaceuticals plcS Sale	Director, Chief Executive Officer	SSale	−1,625 sh	$16.19	−$26.3K	429,398
2024-12-31	Centessa Pharmaceuticals plcF Tax Payment	Director, Chief Executive Officer	FTax Payment	−36.3K sh	$16.35	−$593K	484,398
2024-12-20	Centessa Pharmaceuticals plcS Sale	Director, Chief Executive Officer	SSale	−55K sh	$17.44	−$959K	520,661
2024-12-06	Centessa Pharmaceuticals plcM Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	+87.5K sh	$5.84	+$511K	663,157
2024-12-06	Centessa Pharmaceuticals plcS Sale	Director, Chief Executive Officer	SSale	−87.5K sh	$18.46	−$1.62M	575,661
2024-12-06	Centessa Pharmaceuticals plcShare Option (right to buy)M Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	−87.5K sh	—	—	3,869,485
2024-11-25	Centessa Pharmaceuticals plcM Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	+299 sh	$5.84	+$1,746.16	575,960
2024-11-25	Centessa Pharmaceuticals plcS Sale	Director, Chief Executive Officer	SSale	−299 sh	$18.23	−$5,450.77	575,661
2024-11-25	Centessa Pharmaceuticals plcShare Option (right to buy)M Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	−299 sh	—	—	3,956,981
2024-11-22	Centessa Pharmaceuticals plcM Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	+1,671 sh	$5.84	+$9,758.64	577,332
2024-11-22	Centessa Pharmaceuticals plcS Sale	Director, Chief Executive Officer	SSale	−1,671 sh	$18.24	−$30.5K	575,661
2024-11-22	Centessa Pharmaceuticals plcShare Option (right to buy)M Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	−1,671 sh	—	—	3,957,280
2024-11-21	Centessa Pharmaceuticals plcM Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	+3,511 sh	$5.84	+$20.5K	579,172
2024-11-21	Centessa Pharmaceuticals plcS Sale	Director, Chief Executive Officer	SSale	−3,511 sh	$18.24	−$64K	575,661
2024-11-21	Centessa Pharmaceuticals plcShare Option (right to buy)M Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	−3,511 sh	—	—	3,958,951
2024-11-20	Centessa Pharmaceuticals plcS Sale	Director, Chief Executive Officer	SSale	−55K sh	$16.89	−$929K	575,661
2024-10-23	Centessa Pharmaceuticals plcS Sale	Director, Chief Executive Officer	SSale	−2,592 sh	$15.32	−$39.7K	630,661
2024-10-22	Centessa Pharmaceuticals plcS Sale	Director, Chief Executive Officer	SSale	−30.2K sh	$15.67	−$473K	633,253
2024-10-21	Centessa Pharmaceuticals plcS Sale	Director, Chief Executive Officer	SSale	−22.2K sh	$15.80	−$351K	663,456
2024-09-30	Centessa Pharmaceuticals plcF Tax Payment	Director, Chief Executive Officer	FTax Payment	−36.3K sh	$15.79	−$573K	685,661
2024-09-20	Centessa Pharmaceuticals plcS Sale	Director, Chief Executive Officer	SSale	−55K sh	$16.53	−$909K	721,924
2024-09-10	Centessa Pharmaceuticals plcM Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	+175K sh	$5.84	+$1.02M	951,924
2024-09-10	Centessa Pharmaceuticals plcS Sale	Director, Chief Executive Officer	SSale	−175K sh	$16.52	−$2.89M	776,924
2024-09-10	Centessa Pharmaceuticals plcShare Option (right to buy)M Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	−175K sh	—	—	3,994,485
2024-08-30	CLVTCLARIVATE PLCS Sale	Director	SSale	−17.6K sh	$6.75	−$119K	23,741
2024-08-23	Centessa Pharmaceuticals plcS Sale	Director, Chief Executive Officer	SSale	−46.7K sh	$12.30	−$574K	776,924
2024-08-22	Centessa Pharmaceuticals plcS Sale	Director, Chief Executive Officer	SSale	−506 sh	$12.23	−$6,188.38	823,575
2024-08-21	Centessa Pharmaceuticals plcS Sale	Director, Chief Executive Officer	SSale	−3,674 sh	$12.25	−$45K	824,081

Recent filings

Accepted (ET)
May 154
SAHA SAURABH0001764046-26-000069
SEC(opens sec.gov)
Jul 214
SAHA SAURABH0001847903-25-000119
SEC(opens sec.gov)
Jun 204
SAHA SAURABH0001847903-25-000095
SEC(opens sec.gov)
May 204
SAHA SAURABH0001847903-25-000076
SEC(opens sec.gov)
May 84
SAHA SAURABH0001764046-25-000075
SEC(opens sec.gov)
Apr 224
SAHA SAURABH0001847903-25-000055
SEC(opens sec.gov)
Mar 214
SAHA SAURABH0001847903-25-000045
SEC(opens sec.gov)
Mar 54
SAHA SAURABH0001764046-25-000026
SEC(opens sec.gov)
Feb 204
SAHA SAURABH0001847903-25-000035
SEC(opens sec.gov)
Feb 44
SAHA SAURABH0001847903-25-000027
SEC(opens sec.gov)

Companies

Address

C/O CLARIVATE PLC 70 ST MARY AXE

LONDON, EC3A 8BE